| Year |
Citation |
Score |
| 2020 |
Ross HJ, Hu C, Higgins KA, Jabbour SK, Kozono DE, Owonikoko TK, Movsas B, Solberg T, Xiao C, Williams TM, Welsh JW, Simko J, Wang XF, Mohindra NA, Hsu C, et al. NRG Oncology/Alliance LU005: A phase II/III randomized clinical trial of chemoradiation versus chemoradiation plus atezolizumab in limited stage small cell lung cancer. Journal of Clinical Oncology. 38: TPS9082-TPS9082. DOI: 10.1200/Jco.2020.38.15_Suppl.Tps9082 |
0.366 |
|
| 2020 |
Robbins C, Robbins J, Hsu C, Yi S. Practice Patterns of Head and Neck Radiation for Patients Presenting with De Novo Metastatic Disease: Implication of Radiation Regimen on Survival and Time Spent Receiving Radiation Therapy International Journal of Radiation Oncology Biology Physics. 108. DOI: 10.1016/J.Ijrobp.2020.02.564 |
0.338 |
|
| 2019 |
Kim S, Bull DA, Hsu CH, Hsu CC. The Role of Adjuvant Therapy in Advanced Thymic Carcinoma: A National Cancer Database Analysis. The Annals of Thoracic Surgery. PMID 31877285 DOI: 10.1016/J.Athoracsur.2019.11.009 |
0.356 |
|
| 2019 |
Han JE, Yi SK, Wang S, Erman A, Bearelly S, Sindhu S, Robbins JR, Bauman J, Hsu CC. Neoadjuvant chemotherapy improves survival compared with concurrent chemoradiation alone in nasopharyngeal carcinoma patients with N3 disease. Head & Neck. PMID 31520512 DOI: 10.1002/Hed.25955 |
0.322 |
|
| 2018 |
Kim S, Bull DA, Garland L, Khalpey Z, Stea B, Yi S, Hsu CC. Is There a Role for Cancer Directed Surgery in Early Stage Sarcomatoid or Biphasic Mesothelioma? The Annals of Thoracic Surgery. PMID 30278171 DOI: 10.1016/J.Athoracsur.2018.07.081 |
0.322 |
|
| 2018 |
Stea B, Skrepnik T, Hsu CC, Abendroth R. The role of radiation therapy in the treatment of metastatic cancer. Clinical & Experimental Metastasis. PMID 30062507 DOI: 10.1007/S10585-018-9926-6 |
0.361 |
|
| 2018 |
Fang P, Jiang W, Davuluri R, Xu C, Krishnan S, Mohan R, Koong AC, Hsu CC, Lin SH. High lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 29530432 DOI: 10.1016/J.Radonc.2018.02.025 |
0.317 |
|
| 2018 |
Herman JM, Jabbour SK, Lin SH, Deek MP, Hsu CC, Fishman EK, Kim S, Cameron JL, Chekmareva M, Laheru DA, Narang AK, Pawlik TM, Hruban RH, Wolfgang CL, Iacobuzio-Donahue CA. Smad4 Loss Correlates With Higher Rates of Local and Distant Failure in Pancreatic Adenocarcinoma Patients Receiving Adjuvant Chemoradiation. Pancreas. PMID 29329157 DOI: 10.1097/Mpa.0000000000000985 |
0.316 |
|
| 2018 |
Han J, Yi S, Hsu C. Neoadjuvant Chemotherapy Associated With Improved Survival in High-Risk Nasopharyngeal Carcinoma Patients Treated With Definitive Concurrent Chemoradiation Therapy International Journal of Radiation Oncology*Biology*Physics. 100: 1324-1325. DOI: 10.1016/J.Ijrobp.2017.12.051 |
0.366 |
|
| 2017 |
Shiraishi Y, Fang P, Xu C, Song J, Krishnan S, Koay EJ, Mehran RJ, Hofstetter WL, Blum-Murphy M, Ajani JA, Komaki R, Minsky B, Mohan R, Hsu CC, Hobbs BP, et al. Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 29248170 DOI: 10.1016/J.Radonc.2017.11.028 |
0.355 |
|
| 2017 |
Rao AD, Liu Y, von Eyben R, Hsu CC, Hu C, Rosati LM, Parekh A, Ng K, Hacker-Prietz A, Zheng L, Pawlik TM, Laheru DA, Jaffee EM, Weiss MJ, Le DT, et al. Multiplex Proximity Ligation Assay to Identify Potential Prognostic Biomarkers for Improved Survival in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. PMID 29157747 DOI: 10.1016/J.Ijrobp.2017.10.001 |
0.404 |
|
| 2017 |
Davuluri R, Jiang W, Fang P, Xu C, Komaki R, Gomez DR, Welsh J, Cox JD, Crane CH, Hsu CC, Lin SH. Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 99: 128-135. PMID 28816138 DOI: 10.1016/J.Ijrobp.2017.05.037 |
0.37 |
|
| 2016 |
Rosati LM, Liu Y, Rao AD, Hsu CC, Parekh A, Ng K, Hacker-Prietz A, Zheng L, Laheru DA, Jaffee EM, Le DT, De Jesus-Acosta A, Hruban RH, Pawlik TM, Weiss MJ, et al. Serum Protein Expression and Associations With Conversion to Resectable Status Following Chemotherapy and Stereotactic Body Radiation Therapy in Locally Advanced Pancreatic Adenocarcinoma. International Journal of Radiation Oncology, Biology, Physics. 96: S44. PMID 27675931 DOI: 10.1016/J.Ijrobp.2016.06.117 |
0.358 |
|
| 2016 |
Jiang W, Davuluri R, Fang P, Xu C, Welsh JW, Crane CH, Komaki RU, Cox JD, Hsu CC, Lin SH. Circulating Lymphocyte Count During Neoadjuvant Chemoradiation Therapy for Esophageal Cancer as a Predictive Biomarker of Pathologic Complete Response. International Journal of Radiation Oncology, Biology, Physics. 96: S151. PMID 27675652 DOI: 10.1016/J.Ijrobp.2016.06.366 |
0.33 |
|
| 2016 |
Rao AD, Liu Y, Hsu CC, Parekh A, Rosati LM, Ng K, Hacker-Prietz A, Zheng L, Pawlik TM, Laheru DA, Jaffee EM, Weiss MJ, Le DT, Hruban RH, De Jesus-Acosta A, et al. Multiplex Proximal Ligation Assay Identifies Potential Prognostic Biomarkers for Improved Survival in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 96: E597-E598. PMID 27675116 DOI: 10.1016/J.Ijrobp.2016.06.2126 |
0.387 |
|
| 2016 |
Cao Y, Chen L, Guss ZD, Moore J, Mian OY, Hsu CC, Robertson SP, Rosati LM, Cheng Z, Narang A, Hacker-Prietz A, McNutt TR, Herman JM. Pancreas Stereotactic Body Radiation Therapy Demonstrates Minimal Acute Treatment-Related Toxicity. International Journal of Radiation Oncology, Biology, Physics. 96: E216-E217. PMID 27674086 DOI: 10.1016/J.Ijrobp.2016.06.1134 |
0.307 |
|
| 2016 |
Guss ZD, Rosati LM, Hsu CC, Hacker-Prietz A, He J, Pawlik TM, Makary MA, Hirose K, De Jesus-Acosta A, Le DT, Zheng L, Laheru DA, Cameron JL, Wolfgang CL, Weiss MJ, et al. Neoadjuvant Stereotactic Body Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: Prognostic Factors for Local Recurrence and Survival. International Journal of Radiation Oncology, Biology, Physics. 96: E212-E213. PMID 27674077 DOI: 10.1016/J.Ijrobp.2016.06.1124 |
0.381 |
|
| 2016 |
Davuluri R, Jiang W, Fang P, Xu C, Komaki RU, Hsu CC, Lin SH, Welsh JW, Cox JD, Crane CH. Absolute Lymphocyte Count Nadir During Chemoradiation as a Prognostic Indicator of Esophageal Cancer Survival Outcomes. International Journal of Radiation Oncology, Biology, Physics. 96: E177. PMID 27673979 DOI: 10.1016/J.Ijrobp.2016.06.1035 |
0.324 |
|
| 2016 |
Rosati LM, Hsu CC, Hacker-Prietz A, Rao AD, He J, Pawlik TM, Cameron JL, Makary MA, Hirose K, De Jesus-Acosta A, Le DT, Zheng L, Laheru DA, Wolfgang CL, Weiss MJ, et al. Predictive Factors of Pathologic Response in Patients With Localized Pancreatic Cancer Treated With Induction Chemotherapy and Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 96: E164. PMID 27673948 DOI: 10.1016/J.Ijrobp.2016.06.1005 |
0.382 |
|
| 2015 |
Wang J, Narang AK, Sugar EA, Luber B, Rosati LM, Hsu CC, Fuller CD, Pawlik TM, Miller RC, Czito BG, Tuli R, Crane CH, Ben-Josef E, Thomas CR, Herman JM. Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience. Annals of Surgical Oncology. PMID 26224402 DOI: 10.1245/S10434-015-4685-Y |
0.367 |
|
| 2015 |
Hsu CC, Paciorek AT, Cooperberg MR, Roach M, Hsu IC, Carroll PR. Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: does timing matter? Bju International. PMID 25600860 DOI: 10.1111/Bju.13043 |
0.369 |
|
| 2014 |
Fan KY, Dholakia AS, Wild AT, Su Z, Hacker-Prietz A, Kumar R, Hodgin M, Hsu CC, Le DT, De Jesus-Acosta A, Diaz LA, Laheru DA, Hruban RH, Fishman EK, Brown TD, et al. Baseline hemoglobin-A1c impacts clinical outcomes in patients with pancreatic cancer. Journal of the National Comprehensive Cancer Network : Jnccn. 12: 50-7. PMID 24453292 DOI: 10.6004/Jnccn.2014.0006 |
0.359 |
|
| 2014 |
Crehange G, Izaguirre A, Weinberg V, Hsu CC, Gottschalk AR, Hsu IC, Shinohara K, Carroll P, Roach M. Long-term Outcomes Following Radiation Therapy For Prostate Cancer Patients With Lymph Node Metastases at Diagnosis Treated With and Without Surgery. American Journal of Clinical Oncology. PMID 24441584 DOI: 10.1097/Coc.0000000000000032 |
0.374 |
|
| 2013 |
Fan KY, Dholakia AS, Wild AT, Su Z, Hacker-Prietz A, Kumar R, Hodgin M, Hsu CC, Le DT, De Jesus-Acosta A, Diaz LA, Laheru DA, Hruban RH, Fishman EK, Brown TD, et al. Hemoglobin-A1c level to predict for clinical outcomes in patients with pancreatic cancer. Journal of Clinical Oncology. 31: 4039-4039. DOI: 10.1200/Jco.2013.31.15_Suppl.4039 |
0.37 |
|
| 2012 |
Créhange G, Chen CP, Hsu CC, Kased N, Coakley FV, Kurhanewicz J, Roach M. Management of prostate cancer patients with lymph node involvement: a rapidly evolving paradigm. Cancer Treatment Reviews. 38: 956-67. PMID 22703831 DOI: 10.1016/J.Ctrv.2012.05.005 |
0.347 |
|
| 2011 |
Herman JM, Hsu CC, Fishman EK, Hruban RH, Lin SH, Hacker-Prietz A, Cameron JL, Laheru D, Wolfgang CL, Iacobuzio-Donahue CA. Correlation of DPC4 status with outcomes in pancreatic adenocarcinoma patients receiving adjuvant chemoradiation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 168. PMID 27985649 DOI: 10.1200/Jco.2011.29.4_Suppl.168 |
0.366 |
|
| 2011 |
Wang J, Hsu CC, Fuller CD, Pawlik TM, Miller RC, Czito BG, Tuli R, Ben-Josef E, Herman JM. Multicenter evaluation of adjuvant therapy for gallbladder cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 251. PMID 27985532 DOI: 10.1200/Jco.2011.29.4_Suppl.251 |
0.34 |
|
| 2011 |
Crehange G, Weinberg VK, Izaguirre A, Hsu CC, Hsu IJ, Gottschalk AR, Shinohara K, Carroll P, Roach M. Disease-specific survival outcomes in lymph node-positive patients with prostate cancer treated with radiotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 182. PMID 27968479 DOI: 10.1200/Jco.2011.29.7_Suppl.182 |
0.346 |
|
| 2011 |
Narang AK, Miller RC, Hsu CC, Bhatia S, Pawlik TM, Laheru D, Hruban RH, Zhou J, Winter JM, Haddock MG, Donohue JH, Schulick RD, Wolfgang CL, Cameron JL, Herman JM. Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study. Radiation Oncology (London, England). 6: 126. PMID 21951377 DOI: 10.1186/1748-717X-6-126 |
0.368 |
|
| 2011 |
Hsu CC, Kao WL, Steffes MW, Gambir T, Brancati FL, Heilig CW, Shuldiner AR, Boerwinkle EA, Coresh J. Genetic variation of glucose transporter-1 (GLUT1) and albuminuria in 10,278 European Americans and African Americans: a case-control study in the Atherosclerosis Risk in Communities (ARIC) study. Bmc Medical Genetics. 12: 16. PMID 21247498 DOI: 10.1186/1471-2350-12-16 |
0.404 |
|
| 2011 |
Horowitz DP, Hsu CC, Wang J, Makary MA, Winter JM, Robinson R, Schulick RD, Cameron JL, Pawlik TM, Herman JM. Adjuvant chemoradiation therapy after pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma. International Journal of Radiation Oncology, Biology, Physics. 80: 1391-7. PMID 20643511 DOI: 10.1016/J.Ijrobp.2010.04.003 |
0.342 |
|
| 2011 |
Hsu C, Hsu I, Roach M, Paciorek A, Cooperberg M, Carroll P. Timing of Postoperative Radiation Therapy (PORT) for Patients at High-risk of Recurrence after Radical Prostatectomy (RP): Analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) Study International Journal of Radiation Oncology*Biology*Physics. 81: S74-S75. DOI: 10.1016/J.Ijrobp.2011.06.149 |
0.364 |
|
| 2011 |
Herman J, Hsu C, Fishman E, Lin S, Hacker-Prietz A, Cameron J, Laheru D, Narang A, Wolfgang C, Iacobuzio-Donahue C. Prognostic Value of DPC4 Status for Resected Pancreatic Adenocarcinoma Patients Receiving Adjuvant Chemoradiation International Journal of Radiation Oncology*Biology*Physics. 81: S69. DOI: 10.1016/J.Ijrobp.2011.06.138 |
0.328 |
|
| 2010 |
Hsu CC, Herman JM, Corsini MM, Winter JM, Callister MD, Haddock MG, Cameron JL, Pawlik TM, Schulick RD, Wolfgang CL, Laheru DA, Farnell MB, Swartz MJ, Gunderson LL, Miller RC. Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study. Annals of Surgical Oncology. 17: 981-90. PMID 20087786 DOI: 10.1245/S10434-009-0743-7 |
0.345 |
|
| 2010 |
Voong KR, Davison J, Pawlik TM, Uy MO, Hsu CC, Winter J, Hruban RH, Laheru D, Rudra S, Swartz MJ, Nathan H, Edil BH, Schulick R, Cameron JL, Wolfgang CL, et al. Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients. Human Pathology. 41: 113-22. PMID 19801164 DOI: 10.1016/J.Humpath.2009.07.012 |
0.377 |
|
| 2009 |
Zhou J, Hsu CC, Winter JM, Pawlik TM, Laheru D, Hughes MA, Donehower R, Wolfgang C, Akbar U, Schulick R, Cameron J, Herman JM. Adjuvant chemoradiation versus surgery alone for adenocarcinoma of the ampulla of Vater. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 92: 244-8. PMID 19541379 DOI: 10.1016/J.Radonc.2009.05.006 |
0.317 |
|
| 2009 |
Hsu CC, Brancati FL, Astor BC, Kao WH, Steffes MW, Folsom AR, Coresh J. Blood pressure, atherosclerosis, and albuminuria in 10,113 participants in the atherosclerosis risk in communities study. Journal of Hypertension. 27: 397-409. PMID 19226709 DOI: 10.1097/Hjh.0B013E32831Aede6 |
0.551 |
|
| 2008 |
Herman JM, Swartz MJ, Hsu CC, Winter J, Pawlik TM, Sugar E, Robinson R, Laheru DA, Jaffee E, Hruban RH, Campbell KA, Wolfgang CL, Asrari F, Donehower R, Hidalgo M, et al. Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 3503-10. PMID 18640931 DOI: 10.1200/Jco.2007.15.8469 |
0.317 |
|
| 2008 |
Sapkota A, Hsu CC, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates D, Fabiánová E, Rudnai P, Janout V, Holcatova I, Brennan P, Boffetta P, Hashibe M. Dietary risk factors for squamous cell carcinoma of the upper aerodigestive tract in central and eastern Europe Cancer Causes and Control. 19: 1161-1170. PMID 18512121 DOI: 10.1007/S10552-008-9183-0 |
0.306 |
|
| 2008 |
Köttgen A, Hsu CC, Coresh J, Shuldiner AR, Berthier-Schaad Y, Gambhir TR, Smith MW, Boerwinkle E, Kao WH. The association of podocin R229Q polymorphism with increased albuminuria or reduced estimated GFR in a large population-based sample of US adults. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 52: 868-75. PMID 18499321 DOI: 10.1053/J.Ajkd.2008.02.306 |
0.411 |
|
| 2008 |
Hsu C, Herman J, Corsini M, Winter J, Callister M, Cameron J, Pawlik T, Swartz M, Gunderson L, Miller R. Adjuvant Chemoradiation Therapy after Surgical Resection for 1092 Cases of Pancreatic Adenocarcinoma: The Johns Hopkins Hospital - Mayo Clinic Collaborative Study of Pancreatic Cancer International Journal of Radiation Oncology*Biology*Physics. 72: S13. DOI: 10.1016/J.Ijrobp.2008.06.795 |
0.346 |
|
| 2008 |
Zhou J, Hsu C, Winter J, Pawlik T, Laheru D, Akbar U, Swartz M, Schulick R, Cameron J, Herman J. Adjuvant Therapy for Ampullary Adenocarcinoma: The Johns Hopkins Experience International Journal of Radiation Oncology*Biology*Physics. 72: S243-S244. DOI: 10.1016/J.Ijrobp.2008.06.629 |
0.3 |
|
| 2008 |
Gavini S, Hsu C, Swartz M, Laheru D, Pawlik T, Schulick R, Wolfgang C, Winter J, Cameron J, Herman J. Evaluation of Recurrence Patterns after Adjuvant Chemoradiation Therapy in Patients with Resected Pancreatic Adenocarcinoma at Johns Hopkins Hospital International Journal of Radiation Oncology*Biology*Physics. 72: S260-S261. DOI: 10.1016/J.Ijrobp.2008.06.1692 |
0.344 |
|
| 2007 |
Hsu CC, Chow WH, Boffetta P, Moore L, Zaridze D, Moukeria A, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Brennan P. Dietary risk factors for kidney cancer in Eastern and Central Europe. American Journal of Epidemiology. 166: 62-70. PMID 17456477 DOI: 10.1093/Aje/Kwm043 |
0.303 |
|
| 2007 |
Swartz M, Winter J, Herman J, Hsu C. Examination of Adjuvant Chemoradiation Therapy by Postoperative Tumor Characteristics After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma International Journal of Radiation Oncology*Biology*Physics. 69: S275. DOI: 10.1016/J.Ijrobp.2007.07.1303 |
0.323 |
|
| 2006 |
Hsu CC, Bray MS, Kao WH, Pankow JS, Boerwinkle E, Coresh J. Genetic variation of the renin-angiotensin system and chronic kidney disease progression in black individuals in the atherosclerosis risk in communities study. Journal of the American Society of Nephrology : Jasn. 17: 504-12. PMID 16396964 DOI: 10.1681/Asn.2005050468 |
0.324 |
|
| 2006 |
Hsu CC, Coresh J, Kao WHL. Apolipoprotein E and progression of chronic kidney disease [6] Journal of the American Medical Association. 295: 35-36. DOI: 10.1001/Jama.295.1.35-B |
0.364 |
|
| 2005 |
Hsu CC, Kao WH, Coresh J, Pankow JS, Marsh-Manzi J, Boerwinkle E, Bray MS. Apolipoprotein E and progression of chronic kidney disease. Jama. 293: 2892-9. PMID 15956634 DOI: 10.1001/Jama.293.23.2892 |
0.423 |
|
| Show low-probability matches. |